The association between DEAR1 and breast cancer suggests that DEAR1 polymorphisms could be a susceptibility factor for this disease.3 Besides the obvious role as a key regulator of acinar morphogenesis, DEAR1 gene has recently been considered a regulator of p27 stability, and an inhibitor of cyclin-dependent kinases. This evidence concerns the gene TRIM62 and breast carcinoma.